Discovery and Preclinical

BGI Pharma Solutions

Building on a full portfolio of NGS and proteomics services, BGI offers end-to-end genomics solutions for drug R&D, including target discovery pre-clinical development, biomarker development and clinical trial testing. In addition, we can support and execute molecular diagnostic development, IVD registration and commercialization for the pharmaceutical industry in the Chinese market.

Quick Contact